Company Overview
Snapshot
Founded in May 2026 by Eli Yaacoby, Ana Baroni, and Liwen Yaacoby, ExHeaLifeSpan operates with 1–10 employees. The company has raised $500,000 across one funding round. In July 2026, ExHeaLifeSpan secured pre-seed funding.
Business overview
ExHeaLifeSpan is a health technology company developing a non-invasive diagnostic platform to measure and track biological aging. Its core technology integrates breath volatile organic compound (VOC) analysis with multi-omic data, including blood biomarkers, cognitive assessments, microbiome profiling, and biometric data from wearable devices. The platform aims to identify subclinical age-related physiological declines before symptom manifestation, providing longitudinal tracking of aging trajectories, assessing risk development, and evaluating the efficacy of longevity and medical interventions. The company serves the healthcare and life sciences markets, operating within the Health Tech & Life Sciences sector with a focus on Artificial Intelligence and Sensing technologies.
Log in to access full profile ›Company Intelligence Q&A
- What is ExHeaLifeSpan's primary focus?
- ExHeaLifeSpan focuses on developing a non-invasive diagnostic platform to measure and track biological aging, utilizing breath volatile organic compound (VOC) analysis and multi-omic data integration.
- When was ExHeaLifeSpan founded?
- ExHeaLifeSpan was founded in May 2026.
- Who are the founders of ExHeaLifeSpan?
- The founders of ExHeaLifeSpan are Eli Yaacoby, Ana Baroni, and Liwen Yaacoby.
- What is the total capital raised by ExHeaLifeSpan?
- ExHeaLifeSpan has raised a total of $500,000.
- What is ExHeaLifeSpan's current product stage?
- ExHeaLifeSpan's product is currently in the R&D stage, focusing on the development of its non-invasive diagnostic platform.